COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis.

Kawasaki-like syndrome SARS-CoV-2 multi-system inflammatory disease myocarditis pericarditis vaccine

Journal

Pediatric reports
ISSN: 2036-749X
Titre abrégé: Pediatr Rep
Pays: Switzerland
ID NLM: 101551542

Informations de publication

Date de publication:
01 Sep 2021
Historique:
received: 03 08 2021
revised: 18 08 2021
accepted: 25 08 2021
entrez: 26 9 2021
pubmed: 27 9 2021
medline: 27 9 2021
Statut: epublish

Résumé

The alarming onset of some cases of myocarditis and pericarditis following the administration of Pfizer-BioNTech and Moderna COVID-19 mRNA-based vaccines in adolescent males has recently been highlighted. All occurred after the second dose of the vaccine. Fortunately, none of patients were critically ill and each was discharged home. Owing to the possible link between these cases and vaccine administration, the US and European health regulators decided to continue to investigate the potential causal relationship between COVID-19 mRNA vaccines and myocarditis. In any case, none of the patients fulfilled the criteria for multi-system inflammatory syndrome or Kawasaki-like disease and there was no evidence of acute SARS-CoV-2 infection.

Identifiants

pubmed: 34564344
pii: pediatric13030061
doi: 10.3390/pediatric13030061
pmc: PMC8482102
doi:

Types de publication

Journal Article

Langues

eng

Pagination

530-533

Références

N Engl J Med. 2021 Jul 15;385(3):239-250
pubmed: 34043894
Pediatr Rep. 2021 Jun 01;13(2):257-278
pubmed: 34205837
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):125-129
pubmed: 33507892
Pediatrics. 2020 Dec;146(6):
pubmed: 32994175
JAMA Netw Open. 2021 Jun 1;4(6):e2116420
pubmed: 34110391
JAMA Netw Open. 2021 Jun 1;4(6):e2112596
pubmed: 34115127
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Congenit Heart Dis. 2019 Sep;14(5):868-877
pubmed: 31432626
Lancet Child Adolesc Health. 2021 May;5(5):e12-e13
pubmed: 33713603
J Am Coll Cardiol. 2021 Jan 26;77(3):314-325
pubmed: 33478655
MMWR Morb Mortal Wkly Rep. 2021 May 07;70(18):680-684
pubmed: 33956784
JAMA Pediatr. 2021 Jun 4;:
pubmed: 34086047
N Engl J Med. 2020 Jun 4;382(23):2268-2270
pubmed: 32294339
Pediatrics. 2021 Sep;148(3):
pubmed: 34088762
Int J Cardiol Heart Vasc. 2021 Apr 5;:100778
pubmed: 33842684
Minerva Pediatr (Torino). 2021 Jun;73(3):203-208
pubmed: 33305919
Pediatrics. 2021 Sep;148(3):
pubmed: 34088761

Auteurs

Giuseppe Calcaterra (G)

Department of Cardiology, Postgraduate Medical School of Cardiology, University of Palermo, 90127 Palermo, Italy.

Jawahar Lal Mehta (JL)

Department of Medicine, University of Arkansas for Medical Sciences and the Veterans Affairs Medical Center, Little Rock, AR 72205, USA.

Cesare de Gregorio (C)

Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.

Gianfranco Butera (G)

Cardiology, Cardiac Surgery, and Heart Lung Transplantation Department, ERN, GUAR HEART, Bambino Gesu' Hospital and Research Institute, IRCCS Rome, 00165 Rome, Italy.

Paola Neroni (P)

Neonatal Intensive Care Unit, Department of Surgical Sciences, Policlinico Universitario di Monserrato, University of Cagliari, 09042 Monserrato, Italy.

Vassilios Fanos (V)

Neonatal Intensive Care Unit, Department of Surgical Sciences, Policlinico Universitario di Monserrato, University of Cagliari, 09042 Monserrato, Italy.

Pier Paolo Bassareo (PP)

Department of Cardiology, Mater Misericordiae University Hospital and Our Lady's Children's Hospital Crumlin, University College of Dublin, School of Medicine, D07R2WY Dublin, Ireland.

Classifications MeSH